Answers are grounded in this paper and cite their sources.
VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome is a rare, lateonset, X-linked, somatic disorder characterized by various systemic manifestations, including pancytopenia, airway chondritis, and altered bone marrow, among others. The oral surgical management of patients with VEXAS syndrome is an unexplored component of the comprehensive health plan for these patients. This narrative review aims to provide an overview of VEXAS syndrome, its symptoms, and implications for oral surgery and management. Embase and OVID Medline were searched using terms including, but not limited to, "VEXAS syndrome, pathogenesis, oral surgery, dental, management, and oral health," for articles published in English, with no restrictions on date. Extrapolation of potential risks, based on similar conditions, suggests that patients with VEXAS syndrome may be at an increased risk of bleeding, cardiovascular events, infections, and airway complications during oral surgical procedures. Similarly, extrapolating these findings to oral conditions, patients could have increased risk of temporomandibular disorders and periodontitis due to physiological disease processes, and higher risk of xerostomia and thereby caries, due to adverse effects of drugs used in the treatment of VEXAS syndrome. When performing oral surgery on these patients, depending on their presentation and their individualized risk, it may warrant consideration of supplementary hemostatic measures, antibiotic or antifungal agents when appropriate, extra precautions during sedation, and taking breaks to relax the jaw during appointments. Extra preventive measures, like frequent scaling visits, fluoride application, and saliva substitutes, may be beneficial. Given the complex systemic manifestations affecting patients with VEXAS syndrome, it is advised that oral surgical care is provided in the context of a multidisciplinary approach, in close communication with the patient's medical team and other relevant specialists. Oral surgeons ought to be aware of VEXAS syndrome, its oral and systemic manifestations, and oral surgical management considerations. Further research is required on the pathophysiology of this syndrome, its oral manifestations, and optimal surgical treatment modalities.
No takes yet. Share an insight, caveat, or question.
Hassan El-Awour (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: